Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole exome sequencing of canine mammary tumors

PROVIDER: PRJNA489159 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7780740_1.fastq.gz	Fastqsanger.gz
	SRR7780740_2.fastq.gz	Fastqsanger.gz
	SRR7780750_1.fastq.gz	Fastqsanger.gz
	SRR7780750_2.fastq.gz	Fastqsanger.gz
	SRR7780760_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 765

Similar Datasets

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer.

Project description:Spontaneously occurring canine mammary cancer represents an excellent model of human breast cancer, but is greatly understudied. To better use this valuable resource, we performed whole-genome sequencing, whole-exome sequencing, RNA-seq, and/or high-density arrays on twelve canine mammary cancer cases, including seven simple carcinomas and four complex carcinomas. Canine simple carcinomas, which histologically match human breast carcinomas, harbor extensive genomic aberrations, many of which faithfully recapitulate key features of human breast cancer. Canine complex carcinomas, which are characterized by proliferation of both luminal and myoepithelial cells and are rare in human breast cancer, seem to lack genomic abnormalities. Instead, these tumors have about 35 chromatin-modification genes downregulated and are abnormally enriched with active histone modification H4-acetylation, whereas aberrantly depleted with repressive histone modification H3K9me3. Our findings indicate the likelihood that canine simple carcinomas arise from genomic aberrations, whereas complex carcinomas originate from epigenomic alterations, reinforcing their unique value. Canine complex carcinomas offer an ideal system to study myoepithelial cells, the second major cell lineage of the mammary gland. Canine simple carcinomas, which faithfully represent human breast carcinomas at the molecular level, provide indispensable models for basic and translational breast cancer research.

2014-09-07 | GSE54535 | GEO

The differences in miRNA expression with miRNA microarrays of two-dimensional (2D)- and three-dimensional (3D)-SNP cells

Project description:Canine mammary gland tumors can be used as predictive models for human breast cancer. There are several types of microRNAs common in human breast cancer and canine mammary gland tumors. The functions of microRNAs in canine mammary gland tumors are not well understood. In the present study, we compared the characterization of microRNA expression in two-dimensional and three-dimensional canine mammary gland tumor cell models. The expression of microRNA-210 in the three-dimensional-SNP cells was 10.19 times higher than that in the two-dimensional-SNP cells.

2022-07-07 | GSE203410 | GEO

Microtranscriptome of canine tubulopapillary mammary tumors

Project description:We aimed to describe miRNA expression in tubulopapillary canine mammary tumors.

2026-02-19 | GSE270344 | GEO

Project description:Canine whole exome sequencing

| PRJNA891496 | ENA

Transcriptome of canine tubulopapillary mammary tumors

Project description:We aimed to describe mRNA expression in tubulopapillary canine mammary tumors.

2026-02-19 | GSE270345 | GEO

1H NMR based urinary metabolites profiling dataset of canine mammary tumors

Project description:<p>The identification of efficient and sensitive biomarkers for non-invasive tests is one of the major challenges in cancer diagnosis. To address this challenge, metabolomics is widely applied for identifying biomarkers that detects abnormal changes in cancer patients. Canine mammary tumors exhibit physiological characteristics identical to those in human breast cancer and serve as a useful animal model to conduct breast cancer research. Here, we aimed to provide a reliable large-scale metabolite dataset collected from dogs with mammary tumors, using proton nuclear magnetic resonance spectroscopy. We identified 55 metabolites in urine samples from 20 benign, 87 malignant, and 49 healthy control subjects. This dataset provides details of mammary tumor-specific metabolites in dogs and insights into cancer-specific metabolic alterations that share similar molecular characteristics.</p>

2022-02-24 | MTBLS2550 | MetaboLights

Transcriptome of canine tubulopapillary mammary tumors

Project description:Transcriptome of canine tubulopapillary mammary tumors

| PRJNA1126235 | ENA

Microtranscriptome of canine tubulopapillary mammary tumors

Project description:Microtranscriptome of canine tubulopapillary mammary tumors

| PRJNA1126236 | ENA

Project description:Intratumoral bacteria in canine mammary tumors

| PRJNA866706 | ENA

Whole exome sequencing of MPA/DMBA-induced mouse mammary tumors

Project description:Whole exome sequencing of MPA/DMBA-induced mouse mammary tumors

| PRJEB29718 | ENA